News Stocks Sanofi India Receives ₹2.37 Crore Tax Demand Order from Tamil Nadu Commercial Tax OfficerSanofi India Receives ₹2.37 Crore Tax Demand Order from Tamil Nadu Commercial Tax Officer
Sanofi India Limited disclosed receiving a ₹2.37 crore tax demand order from Tamil Nadu's Commercial Tax Officer for FY 2021-22, comprising ₹1.34 crore in tax, ₹89.33 lakh in interest, and ₹13.43 lakh in penalty. The dispute involves Input Tax Credit claims from FY 2020-21 that were claimed in FY 2021-22, which the tax officer rejected despite company submissions. The company plans to appeal the order before appellate authorities.
*this image is generated using AI for illustrative purposes only.
Sanofi India Limited has received a significant tax demand order from the Commercial Tax Officer in Tiruvalur, Tamil Nadu, totaling ₹2.37 crore for the financial year 2021-22. The pharmaceutical company disclosed this development in compliance with SEBI listing regulations on 20th February 2026.
Tax Demand Breakdown
The order issued by the Commercial Tax Officer presents a comprehensive demand structure across multiple components:
| Component: | Amount (₹) |
|---|---|
| Tax: | 1,34,27,399 |
| Interest: | 89,32,714 |
| Penalty: | 13,42,741 |
| Total Demand: | 2,37,02,854 |
Nature of Dispute
The tax controversy stems from Input Tax Credit (ITC) claims related to FY 2020-21 that were subsequently claimed in FY 2021-22. The Commercial Tax Officer dismissed the company's submissions and reconciliations regarding the eligibility of these ITC claims, leading to the substantial tax demand.
Timeline and Receipt Details
The order was originally dated 30th December 2025, but Sanofi India received the communication on 19th February 2026. This timeline indicates a significant delay between the order issuance and the company's receipt of the official communication.
Company's Response Strategy
Sanofi India has indicated its intention to challenge the order through appropriate legal channels. The company stated it would make an appeal before the appellate authorities, suggesting confidence in its position regarding the ITC claims that were disputed by the tax officer.
Regulatory Compliance
The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, demonstrating the company's commitment to transparency with stakeholders regarding material developments that could impact its operations.
Historical Stock Returns for Sanofi
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.16% | +0.20% | -1.39% | -22.34% | -23.20% | -49.16% |
